A Randomized, Double-Blind, Placebo-Controlled Study of

Project: Research project

Project Details

Description

A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Doses and Dose Regimens of Evinacumab in Patients with Persistent Hypercholesterolemia Despite Maximally Tolerated Lipid Modifying Therapy
StatusActive
Effective start/end date6/1/175/30/22

Funding

  • Regeneron Pharmaceuticals, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.